The Patent Finder

Apceth GmbH & Co. KG

Also on record
Records under this name other than the patents Apceth GmbH & Co. KG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 5 of 5 · Back to Apceth GmbH & Co. KG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,464,806Genetically Modified Mesenchymal Stem Cells Expressing an Immune Response-Stimulating Cytokine to Attract And/Or Activate Immune Cells
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,434,925Genetically modified mesenchymal stem cell that express an exogenous cytotoxic protein
Lapsed on the fee record
Ended Sep 6, 2024 · USPTO record
Lapsed on the fee recordEnded Sep 6, 2024USPTO record
US 7,998,472CD34 stem cell-related methods and compositions
Lapsed on the fee record
Ended Aug 16, 2023 · USPTO record
Lapsed on the fee recordEnded Aug 16, 2023USPTO record
US 8,557,578Expansion medium for CD34-negative stem cells
Lapsed on the fee record
Ended Oct 15, 2021 · USPTO record
Lapsed on the fee recordEnded Oct 15, 2021USPTO record
US 6,361,997Genetically modified CD34-negative adherently growing stem cells and their use in gene therapy
Term ended
Term ended Feb 24, 2021 · USPTO record
Term endedTerm ended Feb 24, 2021USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited